Amer Jaber

A novel needle for subcutaneous injection of interferon beta-1a: effect on pain in volunteers and satisfaction in patients with multiple sclerosis

Amer Jaber, Gian B Bozzato, Lionel Védrine et al. · BMC Neurology · 2008 · 62 citations · Full text

Assessment of the immunogenicity of different interferon beta-1a formulations using ex vivo T-cell assays

Amer Jaber, Matthew Baker · Journal of Pharmaceutical and Biomedical Analysis · 2006 · 59 citations

Allergy, Autoimmune Disease, Laboratory Immunology +9

Short Communication: A Comparison of the Biologic Activity of Two Recombinant IFN- <i>β</i> Preparations Used in the Treatment of Relapsing-Remitting Multiple Sclerosis

F Antonetti, Ornella Finocchiaro, Michele Mascia et al. · Journal of Interferon & Cytokine Research · 2002 · 47 citations

Immunogenicity and tolerability of an investigational formulation of interferon-β1a: 24- and 48-week interim analyses of a 2-year, single-arm, historically controlled, phase IIIb study in adults with multiple sclerosis

Gavin Giovannoni, Florence Casset‐Semanaz, Amer Jaber et al. · Clinical Therapeutics · 2007 · 42 citations

Clinical Immunology, 48-Week Interim Analyses, Autoimmune Disease +12

Immunogenicity comparison of interferon beta-1a preparations using the BALB/c mouse model: assessment of a new formulation for use in multiple sclerosis.

Francesca Bellomi, Antonella Muto, G. Palmieri et al. · PubMed · 2007 · 15 citations

Clinical Immunology, New Formulation, Rebif New Formulation +17